Biogen U.S. Corporation
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 900 Davis Drive, Morrisville, North Carolina (NC) 27560, United States (USA)
- Operations here
- analysismanufacture
- FDA identifiers
- FEI 3010164829 · DUNS 078734950
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBlood and Blood Products2023-10-17
- VAIDrug Quality Assurance2022-08-26
- VAIDrug Quality Assurance2015-12-10
- NAIDrug Quality Assurance2015-04-16
Drugs this plant is listed as making
2 distinct drugs across 8 products name this site in their FDA label.
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtlBioverativ Therapeutics Inc.
- TocilizumabBiogen MA Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.